Sanofi India reported 23% fall in net profit to Rs 90.40 crore on a 4.5% fall in net sales to Rs 687.90 crore in Q4 December 2021 over Q4 December 2020.
Total expenditure rose 1.3% YoY to Rs 56.70 crore in the fourth quarter, primarily due to higher raw material costs (up 85.3% YoY) and higher other expenses (up 10.8% YoY).
Profit before tax in Q4 December 2021 stood at Rs 132.20 crore, down 22.3% YoY.
The full-year PAT increased by 98% to Rs 944.4 crore in 2021 from Rs 477.6 crore in 2020.
The total revenue for the year 2021 stood at Rs 2,956.6 crore with a year-on-year growth of 2%. The domestic business delivered strong growth of 13% (excluding the impact of the divestment transactions).
The company approved a final dividend of Rs 490 per share, which includes a special dividend of Rs 309 per share.
The divestment of the companys nutraceuticals business in Q3 2021 and the sale of its Ankleshwar Site in Q2 2020 have contributed to the lower operational cost. The profit before tax increased to Rs 1,257.6 crore in the year 2021 from Rs 677.2 crore in the year 2020, an increase of Rs 5,804 million, on account of profit from the sale of the nutraceuticals business of Rs 489.2 crore in 2021 and an increase in operating profit. The return on capital employed was 34.6% (without exceptional items) as compared to 34% in the previous year.
Rajaram Narayanan, managing director, Sanofi India, ?We have continued to grow our business in key therapies, while transforming our operations in all areas of the company. Our solid 13% domestic market growth is testimony to their efforts.?
Sanofi India is one of the entities through which Sanofi operates in India. It offers a wide array of medicines for therapy areas such as diabetes, cardiology, thrombosis, central nervous system and anti-histamines. The products manufactured by the company are distributed in India and exported to many developed as well as developing countries.
The scrip was currently trading 0.36% higher at Rs 7303.95 on the BSE.
Powered by Capital Market - Live News
Jun 27, 2022
Jun 27, 2022
Jun 27, 2022
Jun 27, 2022
Jun 27, 2022
Jun 27, 2022
Jun 27, 2022
Jun 27, 2022
Jun 27, 2022
Jun 27, 2022
Jun 27, 2022
Jun 27, 2022
Jun 27, 2022
Jun 27, 2022
Jun 27, 2022
The laws of the financial world are different from the physical world. You can have prolonged periods of time, when sanity takes a back seat and excesses happen.
R. Venkataraman Aug 20, 2021
Retail trading or day trading has exploded because of falling brokerage rates, democratization of information, higher transparency and mobile platforms.
R. Venkataraman Jun 15, 2021
My simple message for dear readers is, if you don’t have any desperate need for funds, then don’t do anything.
R. Venkataraman May 12, 2021
The blow up of a US hedge fund has resulted in WhatsApp university offering many courses on what went wrong with Bill Hwang and Archegos.
R. Venkataraman Apr 09, 2021
The expensive valuations have been sustained by strong rebound in corporate earnings which led to ~8% upgrade in FY22 Nifty EPS since October 2020.
R. Venkataraman Mar 26, 2021
We believe the interest rates are likely to have bottomed due to inflationary pressure, large government borrowings and normalizing credit growth. Hence rate sensitive sectors should be avoided in our view.
R. Venkataraman Feb 17, 2021
As markets make new highs, one gets more emails and messages, which highlight the accomplishments of traders who have found a formula for making money.
R. Venkataraman Jan 27, 2021
Data does not seem to convincingly prove that short periods of high returns are always followed by meagre returns. Only in 4 instances, we had negative returns in the subsequent year.
R. Venkataraman Jan 01, 2021
Since September end, Bankex is up 16% with large banks like ICICI Bank, Bandhan up 20-27%, Housing Finance Companies like Repco, LICHF, PNB Housing are up 50%-100% from their six-month lows.
R. Venkataraman Oct 13, 2020
Morgan Housel’s 'The Psychology of Money' explains in detail the role of human biases in investment decisions.
R. Venkataraman Sep 26, 2020
Per Order for ETF & Mutual Funds Brokerage
Per Order for Delivery, Intraday, F&O, Currency & Commodity